Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ai-Mei Gao has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Zun-Ping Ke

    Department of Geriatrics, Shanghai Fifth People’s Hospital, Fudan University, Shanghai 200240, China

    2 shared publications
  • Guzailinur Silimu

    Department of Cardiology, People’s Hospital of Zepu County, Xinjiang 844899, China

    1 shared publication
  • Peng Xu

    Department of Cardiology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China

    1 shared publication
  • Xiao-Yu Zhang

    Division of Gastrointestinal Surgery, Department of General Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China

    1 shared publication
  • Yan Shi

    Department of Emergency, The Affiliated Huai'an Hospital of Xuzhou Medical College and The Second People's Hospital of Huai'an, Huai'an, China

    1 shared publication
  • Yuling Wang

    Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai 200433, China

    1 shared publication

Latest Publications

  • Open Access

    Pharmacology-Based Prediction of the Targets and Mechanisms for Icariin against Myocardial Infarction

    by Zunping Ke, Yuling Wang, Guzailinur Silimu, Zhangsheng Wang, Aimei Gao

    Background and Objectives: This study aims to illustrate the mechanisms underlying the therapeutic effect of Icariin after myocardial infarction (MI). Materials and Methods: Based on the network pharmacology strategy, we predict the therapeutic targets of Icariin against MI and investigate the pharmacological molecular mechanisms. A topological network was created. Biological process and Kyoto Encyclopedia of Genes and Genomes pathway enrichment were also performed. We also conducted the molecular docking analysis to stimulate the component–target interaction further and validate the direct bind effect. Results: Network pharmacology analysis identified 61 candidate genes related to the therapeutic effect of Icariin against MI. EGFR, AKT1, TP53, JUN, ESR1, PTGS2, TNF, RELA, HSP90AA1, and BCL2L1 were identified as hub genes. The biological processes of the candidate targets were significantly involved in the reactive oxygen species metabolic process, response to hypoxia, response to decreased oxygen levels, response to oxidative stress, regulation of reactive oxygen species metabolic process, and so forth. Overall, biological process enrichment analysis indicated that the protective effect of Icariin against MI might be associated with oxidative stress. Moreover, the pathway analysis showed that the candidate targets were closely associated with lipid and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications, HIF-1 signaling pathway, etc. We identified the conformation with the lowest affinity score as the docking conformation. The simulated molecular docking was displayed to illustrate the topical details of the binding sites between Icariin and TNF protein. Conclusions: This study provides an overview of the mechanisms underlying the protective effect of Icariin against MI.


  • Open Access

    Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway

    by Ai-Mei Gao, Xiao-Yu Zhang, Zun-Ping Ke

    Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway Apigenin sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway


  • Open Access

    MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN

    by Zun-Ping Ke, Peng Xu, Yan Shi, Ai-Mei Gao

    MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN